Watchlist Price Alert

Boston Scientific Corpora... (BSX)

NYSE: BSX · Real-Time Price · USD

101.70

1.96 (1.97%)

At close: Jun 16, 2025, 2:08 PM

1.97% (1D)

Bid	101.7
Market Cap	150.46B
Revenue (ttm)	17.55B
Net Income (ttm)	2.03B
EPS (ttm)	1.36
PE Ratio (ttm)	74.78
Forward PE	29.91
Analyst	Buy

Ask	101.71
Volume	4,713,944
Avg. Volume (20D)	8,172,558
Open	100.45
Previous Close	99.74
Day's Range	100.44 - 102.39
52-Week Range	71.88 - 107.17
Beta	0.69

About BSX

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol BSX

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for BSX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Why Price Moved

1 month ago

+4.02%

Boston Scientific shares are trading higher after ... Unlock content with Pro Subscription

4 months ago

+1.38%

Boston Scientific shares are trading higher after the company reported better-than-expected Q4 EPS and revenue.

News

Just now · forbes.com

What's Happening With Boston Scientific Stock?

Boston Scientific (NYSE:BSX) has experienced a stock price increase of over 30% in the last twelve months, greatly exceeding the S&P 500's gain of 9%. This remarkable performance can be credited to th...

3 days ago · zacks.com

Why the Market Dipped But Boston Scientific (BSX) Gained Today

The latest trading day saw Boston Scientific (BSX) settling at $99.74, representing a +1.2% change from its previous close.

2 days ago · zacks.com

PAHC vs. BSX: Which Stock Should Value Investors Buy Now?

Investors interested in Medical - Products stocks are likely familiar with Phibro Animal Health (PAHC) and Boston Scientific (BSX). But which of these two stocks is more attractive to value investors?

2 days ago · zacks.com

BSX Q1 Endoscopy Sales Rise 6%: What's Behind the Growth?

Boston Scientific's Q1 2025 Endoscopy sales jump 6%, powered by innovation in stents, clips and surgical tools for GI care.

5 days ago · zacks.com

Cardiovascular Tailwind Boosts BSX: Here's How to Play the Stock

Boston Scientific BSX, a prominent global player in cardiovascular technology, is well-positioned to capitalize on the robust expansion of the cardiovascular devices market. According to a MarketsandM...

1 week ago · zacks.com

Boston Scientific (BSX) Upgraded to Buy: Here's Why

Boston Scientific (BSX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

1 week ago · zacks.com

Is Boston Scientific (BSX) Stock Outpacing Its Medical Peers This Year?

Here is how Boston Scientific (BSX) and Dare Bioscience, Inc. (DARE) have performed compared to their sector so far this year.

1 week ago · zacks.com

Wall Street Bulls Look Optimistic About Boston Scientific (BSX): Should You Buy?

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analy...